Literature DB >> 17265155

Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis?

Hakan Erdem1, Salih Pay, Ugur Musabak, Ismail Simsek, Ayhan Dinc, Aysel Pekel, Ali Sengul.   

Abstract

In our previous studies, we found higher synovial fluid (SF) levels of angiogenic ELR(+) CXC chemokines such as CXCL1, CXCL5, CXCL6 and CXCL8, which play an important role in neutrophil migration and angiogenesis, and more abundant synovial CXCR2 chemokine receptor expression in patients with rheumatoid arthritis (RA) than those with Behçet's disease (BD), familial Mediterranean fever and osteoarthritis (OA). As a continuation of our previous studies, we investigated synovial levels of angiostatic non-ELR CXC chemokines (CXCL4, CXCL9 and CXCL10) in patients with RA, BD, spondyloarthritis (SpA), and OA. Seventy (17 RA, 15 BD, 19 SpA, and 19 OA) patients were enrolled in the study. The levels of CXCL4, CXCL9, and CXCL10 were measured by ELISA. The SF levels of CXCL4 in patients with RA were higher than those of the patients with BD, SpA, and OA (P = 0.007, P = 0.022, and P = 0.017, respectively). No difference was found with respect to CXCL4 levels among the BD, SpA, and OA patients. The synovial CXCL9 levels of patients with RA and SpA were found to be higher than those of the patients with OA (P = 0.002 and P = 0.005, respectively), while no statistically significant difference was detected among the other groups. With regard to SF CXCL10 levels, patients with RA had higher levels as compared to patients with OA (P = 0.002), but no significant difference was found among the other groups. CXCL9 correlated with CXCL4 and CXCL10 (P < 0.05 for both) in patients with RA. No correlation was found in other parameters. The angiostatic non-ELR CXC chemokines were expressed in synovial inflammation. We proposed that angiostatic non-ELR CXC chemokines may increase to balance angiogenic ELR (+) CXC chemokines in which increased levels were shown in patients with inflammatory arthritides and CXCL4 may contribute to designate the chronicity of synovitis in patients with RA. In addition, as CXCL-9 and CXCL-10 play crucial role in inflammation characterized by Th1 polarization, we suggested that they may contribute to the commencement and the perpetuation of synovitis seen in these groups of arthritides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17265155     DOI: 10.1007/s00296-007-0317-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

Review 1.  CXC chemokines: the regulatory link between inflammation and angiogenesis.

Authors:  Paola Romagnani; Laura Lasagni; Francesco Annunziato; Mario Serio; Sergio Romagnani
Journal:  Trends Immunol       Date:  2004-04       Impact factor: 16.687

2.  The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis.

Authors:  L H Calabrese; B A Michel; D A Bloch; W P Arend; S M Edworthy; A S Fauci; J F Fries; G G Hunder; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

3.  Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

Authors:  Salih Pay; Hakan Erdem; Aysel Pekel; Ismail Simsek; Ugur Musabak; Ali Sengul; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

Review 4.  CXC chemokines in angiogenesis.

Authors:  Robert M Strieter; Marie D Burdick; Brigitte N Gomperts; John A Belperio; Michael P Keane
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-19       Impact factor: 7.638

Review 5.  Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response.

Authors:  A Manzo; R Caporali; C Montecucco; C Pitzalis
Journal:  Clin Exp Rheumatol       Date:  2003 Jul-Aug       Impact factor: 4.473

Review 6.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

7.  The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.

Authors:  R M Strieter; P J Polverini; S L Kunkel; D A Arenberg; M D Burdick; J Kasper; J Dzuiba; J Van Damme; A Walz; D Marriott
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

8.  Expression of CXCR-1 and CXCR-2 chemokine receptors on synovial neutrophils in inflammatory arthritides: does persistent or increasing expression of CXCR-2 contribute to the chronic inflammation or erosive changes?

Authors:  Salih Pay; Ugur Musabak; Ismail Simşek; Aysel Pekel; Hakan Erdem; Ayhan Dinç; Ali Sengül
Journal:  Joint Bone Spine       Date:  2006-07-18       Impact factor: 4.929

9.  Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint.

Authors:  A E Koch; M V Volin; J M Woods; S L Kunkel; M A Connors; L A Harlow; D C Woodruff; M D Burdick; R M Strieter
Journal:  Arthritis Rheum       Date:  2001-01

10.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10
View more
  6 in total

1.  Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides.

Authors:  Mahmut Gok; Hakan Erdem; Feride Gogus; Sedat Yilmaz; Omer Karadag; Ismail Simsek; Rahsan Ilikci Sagkan; Mutlu Saglam; Ugur Musabak; Ayhan Dinc; Salih Pay
Journal:  Rheumatol Int       Date:  2012-07-19       Impact factor: 2.631

2.  Integrative analysis for identification of shared markers from various functional cells/tissues for rheumatoid arthritis.

Authors:  Wei Xia; Jian Wu; Fei-Yan Deng; Long-Fei Wu; Yong-Hong Zhang; Yu-Fan Guo; Shu-Feng Lei
Journal:  Immunogenetics       Date:  2016-11-03       Impact factor: 2.846

3.  Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.

Authors:  C Trocmé; H Marotte; A Baillet; B Pallot-Prades; J Garin; L Grange; P Miossec; J Tebib; F Berger; M J Nissen; R Juvin; F Morel; P Gaudin
Journal:  Ann Rheum Dis       Date:  2008-07-29       Impact factor: 19.103

Review 4.  Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.

Authors:  Silvia Menegatti; Elisabetta Bianchi; Lars Rogge
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

5.  Osteoarthritic Milieu Affects Adipose-Derived Mesenchymal Stromal Cells.

Authors:  Cristina Manferdini; Francesca Paolella; Elena Gabusi; Luca Cattini; Markus Rojewski; Hubert Schrezenmeier; Olga Addimanda; Riccardo Meliconi; Gina Lisignoli
Journal:  J Orthop Res       Date:  2019-08-30       Impact factor: 3.494

6.  Do synovial biopsies help to support evidence for involvement of innate immunity in the immunopathology of Behçet's disease?

Authors:  Jan A M van Laar; Jasper H Kappen; Paul L A van Daele; P Martin van Hagen
Journal:  Arthritis Res Ther       Date:  2009-04-30       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.